Open-angle glaucoma

American Family Physician

Volumn 67, Issue 9, 2003, Pages 1937-1944+1950

  Distelhorst, James S ^a   Hughes, Grady M ^b,c  

^a MILLIMAN INC   (United States)

^b Swedish Med Ctr/Providence Campus ^*  (United States)

^c Division of Ophthalmology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARTEOLOL; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

BRADYCARDIA; BRONCHOSPASM; DIABETES MELLITUS; DRUG COST; FAMILY HISTORY; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MYOPIA; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; OPTOMETRY; PERIMETRY; REVIEW; UNITED STATES; VISUAL FIELD; VISUAL IMPAIRMENT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; BLINDNESS; GLAUCOMA, OPEN-ANGLE; HUMANS; MASS SCREENING; OPHTHALMIC SOLUTIONS;

EID: 0038218469     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Weston BC, Aliabadi Z, White GL. Glaucoma - review for the vigilant clinician. Clinician Reviews 2000;10:59-74.
2. American Academy of Ophthalmology, Glaucoma Panel. Primary open-angle glaucoma. Preferred practice pattern. San Francisco: American Academy of Ophthalmology, 2000:1-36.
3. Vaughan D, Riordan-Eva P. Glaucoma. In: Vaughan D, Asbury T, Riordan-Eva P, eds. General ophthalmology. 15th ed. Stamford, Conn.: Appleton & Lange, 1999:200-15.
4. Riordan-Eva P, Vaughan DG. Eye. In: Tierney LM Jr, McPhee SJ, Papadakis MA, eds. Current medical diagnosis & treatment, 2001. 40th ed. New York: Lange Medical Books/McGraw-Hill, 2001:185-216.
5. Alward WL. Medical management of glaucoma. N Engl J Med 1998;339:1298-307.
6. Infeld DA, O'Shea JG. Glaucoma: diagnosis and management. Postgrad Med J 1998;74:709-15.
7. Barnebey H. Screening for glaucoma. In: Fihn SD, DeWitt DE, eds. Outpatient medicine. 2d ed. Philadelphia: Saunders, 1998:119-20.
8. American Academy of Ophthalmology, Glaucoma Panel. Primary open-angle glaucoma suspect. Preferred practice pattern. San Francisco: American Academy of Ophthalmology, 2000:1-26.
9. Grierson I. The patient with primary open-angle glaucoma. Practitioner 2000;244:654-8.
10. Sponsel WE. Glaucoma. In: Conn HF, Rakel RE, eds. Conn's Current therapy 2001: latest approved methods of treatment for the practicing physician. Philadelphia: Saunders, 2001:976-9.
11. Horton JC. Disorders of the eye. In: Harrison TR, Braunwald E, eds. Harrison's Principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001:164-78.
12. American Academy of Ophthalmology. Optic nerve head and retinal nerve fiber layer analysis. Ophthalmology 1999;106:1414-24.
13. U.S. Preventive Services Task Force. Screening for glaucoma. In: DiGuiseppi C, Atkins D, Woolf SH, eds. Guide to clinical preventive services. 2d ed. Baltimore: Williams & Wilkins, 1996.
14. Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye 1999;13(Pt 5):613-6.
15. Leibowitz HM. The red eye. N Engl J Med 2000; 343:345-51.
16. Sharma S, Cheung J. Ophthaproblem. Acute angle-closure glaucoma. Can Fam Physician 2000; 46:303,310-2.
17. American Academy of Ophthalmology, Glaucoma Panel. Primary angle closure. Preferred practice pattern. San Francisco: American Academy of Ophthalmology, 2000:1-20.
18. Kendrick R. Gradual painless visual loss: glaucoma. Clin Geriatr Med 1999; 15:95-101.
19. Dayan M, Turner B, McGhee C. Acute angle closure glaucoma masquerading as systemic illness. BMJ 1996;313:413-5.
20. Duguid G. Red eye: avoid the pitfalls. Practitioner 1997;241:188-90,192,194-5.
21. Morgan A, Hemphill RR. Acute visual change. Emerg Med Clin North Am 1998;16:825-43.
22. O'Brien C, Diamond J. Eye disorders: glaucoma. In: Godlee F, ed. Clinical evidence. London: BMJ Publishing Group, 2000.
23. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
24. Heijl A, Leske C, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120:1268-79.
25. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003;121:48-56.
26. King A, Migdal C. Clinical management of glaucoma. J R Soc Med 2000;93:175-7.
27. Drug facts and comparisons 2002. 56th ed. St. Louis: Facts & Comparisons, 2002:1875.
28. Schuman JS. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Ophthalmology 2000;107:1171-7.
29. Brimonidine: an alpha 2-agonist for glaucoma. Med Lett Drugs Ther 1997;39(1002):54-5.
30. Brinzolamide - a new topical carbonic anhydrase inhibitor for glaucoma. Med Lett Drugs Ther 1998;40(1036):95-6.
31. Boyle JE, Ghosh K, Gieser DK, Adamsons IA. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology 1999; 106(12 Suppl):10-6.
32. Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, et al. One-year randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 2002;120:1286-93.
33. Hedman K, Alm A. A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol 2000; 10:95-104.
34. Alm A, Widengard I. Latanoprost: experience of 2-year treatment in Scandinavia. Acta Ophthalmol Scand 2000;78:71-6.